Skip to main content

Advertisement

SpringerLink
Log in

Vitamin D and bone health status in beta thalassemia patients—systematic review

  • Review
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Thalassemia is a chronic congenital disease characterized by a combination of endocrine and metabolic disorders. Bone disease is a very common complication related to the poor absorption of calcium, the secondary chronic renal disease with low vitamin D, as well as multiple endocrine risk factors. The aim of this systematic review was to estimate the prevalence of vitamin D deficiency in thalassemia, as well as its association with osteoporosis/low bone mass. A systematic review was carried out using PubMed/Medline, Cochrane, and EBSCO databases. The methodological quality of the included studies was assessed with the validated Newcastle–Ottawa Quality Assessment Scale adapted for cross-sectional studies and cohort studies respectfully and the Cochrane Collaboration for clinical trials. After application of predetermined exclusion criteria compatible with the PICOS process, a total of 12 suitable articles were identified. The prevalence of vitamin D deficiency varied considerably. Only five of the reviewed studies examined the correlation between vitamin D levels and BMD of which just three showed a statistically significant positive association of mild/moderate grade. Vitamin D deficiency is a common comorbidity in patients with thalassemia. However, both its prevalence and its severity vary considerably in different populations, and existing evidence is insufficient to conclude whether vitamin D supplementation is also associated with BMD improvement in this special population group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Higgs DR, Engel JD, Stamatoyannopoulos G (2012) Thalassaemia. Lancet 379:373–383. https://doi.org/10.1016/S0140-6736(11)60283-3

    Article  CAS  PubMed  Google Scholar 

  2. Modell B, Darlison M (2008) Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 86:480–487. https://doi.org/10.2471/BLT.06.036673

    Article  PubMed  PubMed Central  Google Scholar 

  3. Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Strauss BJ, Bowden D, Milat F (2013) Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fractures. Osteoporos Int 24:1965–1971. https://doi.org/10.1007/s00198-012-2260-y

    Article  CAS  PubMed  Google Scholar 

  4. De Sanctis V, Eleftheriou A, Malaventura C (2004) Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). Pediatr Endocrinol Rev 2:249–255

    PubMed  Google Scholar 

  5. Weidlich D, Kefalas P, Guest JF (2016) Healthcare costs and outcomes of managing β-thalassemia major over 50 years in the United Kingdom. Transfusion 56:1038–1045. https://doi.org/10.1111/trf.13513

    Article  PubMed  Google Scholar 

  6. Origa R (2017) β-Thalassemia. Genet Med 19:609–619. https://doi.org/10.1038/gim.2016.173

    Article  CAS  PubMed  Google Scholar 

  7. Fink H (1964) Transfusion hemochromatosis in Cooley’s anemia. Ann N Y Acad Sci 119:680–685. https://doi.org/10.1111/j.1749-6632.1965.tb54068.x

    Article  CAS  PubMed  Google Scholar 

  8. Musallam K, Cappellini MD, Taher A (2008) Challenges associated with prolonged survival of patients with thalassemia: Transitioning from childhood to adulthood. Pediatrics 121:e1426–e1429. https://doi.org/10.1542/peds.2007-1944

    Article  PubMed  Google Scholar 

  9. Gaudio A, Morabito N, Catalano A, Rapisarda R, Xourafa A, Lasco A (2019) Pathogenesis of thalassemia major-associated osteoporosis: a review with insights from clinical experience. J Clin Res Pediatr Endocrinol 11:110–117. https://doi.org/10.4274/jcrpe.galenos.2018.2018.0074

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lertsuwan K, Wongdee K, Teerapornpuntakit J, Charoenphandhu N (2018) Intestinal calcium transport and its regulation in thalassemia: interaction between calcium and iron metabolism. J Physiol Sci 68:221–232. https://doi.org/10.1007/s12576-018-0600-1

    Article  CAS  PubMed  Google Scholar 

  11. Yu U, Chen L, Wang X, Zhang X, Li Y, Wen F, Liu S (2019) Evaluation of the vitamin D and biomedical statuses of young children with β-thalassemia major at a single center in southern China. BMC Pediatr 19:375. https://doi.org/10.1186/s12887-019-1744-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. De Sanctis V, Elsedfy H, Soliman AT, Elhakim IZ, Kattamis C, Soliman NA et al (2016) Clinical and biochemical data of adult thalassemia major patients (TM) with multiple endocrine complications (MEC) versus TM patients with normal endocrine functions: a long-term retrospective study (40 years) in a tertiary care center in Italy. Mediterr J Hematol Infect Dis 8:e2016022. https://doi.org/10.4084/MJHID.2016.022

    Article  PubMed  PubMed Central  Google Scholar 

  13. Pellegrino F, Zatelli MC, Bondanelli M, Carnevale A, Cittanti C, Fortini M, Gamberini MR, Giganti M, Ambrosio MR (2019) Dual-energy X-ray absorptiometry pitfalls in thalassemia major. Endocrine 65:469–482. https://doi.org/10.1007/s12020-019-02003-x

    Article  CAS  PubMed  Google Scholar 

  14. De Sanctis V, Soliman AT, Elsefdy H, Soliman N, Bedair E, Fiscina B et al (2018) Bone disease in β thalassemia patients: past, present and future perspectives. Metabolism 80:66–79. https://doi.org/10.1016/j.metabol.2017.09.012

    Article  CAS  PubMed  Google Scholar 

  15. Farmakis D, Giakoumis A, Angastiniotis M, Eleftheriou A (2020) The changing epidemiology of the ageing thalassaemia populations: a position statement of the Thalassaemia International Federation. Eur J Haematol 105:16–23. https://doi.org/10.1111/ejh.13410

    Article  PubMed  Google Scholar 

  16. Piga A (2017) Impact of bone disease and pain in thalassemia. Hematology 2017:272–277. https://doi.org/10.1182/asheducation-2017.1.272

    Article  PubMed  PubMed Central  Google Scholar 

  17. Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G et al (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 6:e1000097. https://doi.org/10.1371/journal.pmed.1000097

    Article  PubMed  PubMed Central  Google Scholar 

  18. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.0.1. The Cochrane collaboration. Http://WwwCochrane-HandbookOrg 2008.

  19. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. Ottawa Hospital Research Institute n.d. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp ().

  20. van Tulder M, Furlan A, Bombardier C, Bouter L (2003) Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine (Phila Pa 1976) 28:1290–1299. https://doi.org/10.1097/01.brs.0000065484.95996.af

    Article  Google Scholar 

  21. Bordbar M, Bozorgi H, Saki F, Haghpanah S, Karimi M, Bazrafshan A, Zekavat OR (2019) Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran. J Endocrinol Investig 42:1467–1476. https://doi.org/10.1007/s40618-019-01072-z

    Article  CAS  Google Scholar 

  22. Doulgeraki A, Athanasopoulou H, Voskaki I, Tzagaraki A, Karabatsos F, Fragodimitri C, Georgakopoulou E, Iousef J, Monopolis I, Chatziliami A, Karagiorga M (2012) Bone health evaluation of children and adolescents with homozygous β-thalassemia: implications for practice. J Pediatr Hematol Oncol 34:344–348. https://doi.org/10.1097/MPH.0b013e3182431ddb

    Article  CAS  PubMed  Google Scholar 

  23. Merchant R, Udani A, Puri V, D’Cruz V, Patkar D, Karkera A (2010) Evaluation of osteopathy in thalassemia by bone mineral densitometry and biochemical indices. Indian J Pediatr 77:987–991. https://doi.org/10.1007/s12098-010-0158-2

    Article  PubMed  Google Scholar 

  24. Napoli N, Carmina E, Bucchieri S, Sferrazza C, Rini GB, Di Fede G (2006) Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone 38:888–892. https://doi.org/10.1016/j.bone.2005.11.018

    Article  CAS  PubMed  Google Scholar 

  25. Mahachoklertwattana P, Chuansumrit A, Sirisriro R, Choubtum L, Sriphrapradang A, Rajatanavin R (2003) Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with β-thalassaemia disease. Clin Endocrinol 58:273–279. https://doi.org/10.1046/j.1365-2265.2003.01707.x

    Article  CAS  Google Scholar 

  26. Baldini M, Ulivieri FM, Forti S, Serafino S, Seghezzi S, Marcon A, Giarda F, Messina C, Cassinerio E, Aubry-Rozier B, Hans D, Cappellini MD (2014) Spine bone texture assessed by trabecular bone score (TBS) to evaluate bone health in thalassemia major. Calcif Tissue Int 95:540–546. https://doi.org/10.1007/s00223-014-9919-7

    Article  CAS  PubMed  Google Scholar 

  27. Thiagarajan NR, Kumar CGD, Sahoo J, Krishnamurthy S (2019) Effect of vitamin D and calcium supplementation on bone mineral content in children with thalassemia. Indian Pediatr 56:307–310

    Article  CAS  PubMed  Google Scholar 

  28. Abbassy HA, Abo Elwafa RA, Omar OM (2019) Bone mineral density and Vitamin D receptor genetic variants in Egyptian children with beta thalassemia major on Vitamin D supplementation. Mediterr J Hematol Infect Dis 11:e2019013. https://doi.org/10.4084/MJHID.2019.013

    Article  PubMed  PubMed Central  Google Scholar 

  29. Meena MC, Hemal A, Satija M, Arora SK, Bano S (2015) Comparison of bone mineral density in thalassemia major patients with healthy controls. Adv Hematol 2015:1–4. https://doi.org/10.1155/2015/648349

    Article  CAS  Google Scholar 

  30. Isik P, Yarali N, Tavil B, Demirel F, Karacam GB, Sac RU, Fettah A, Ozkasap S, Kara A, Tunc B (2014) Endocrinopathies in Turkish children with beta thalassemia major: results from a single center study. Pediatr Hematol Oncol 31:607–615. https://doi.org/10.3109/08880018.2014.898724

    Article  CAS  PubMed  Google Scholar 

  31. Tzoulis P, Ang AL, Shah FT, Berovic M, Prescott E, Jones R, Barnard M (2014) Prevalence of low bone mass and vitamin d deficiency in β-thalassemia major. Hemoglobin 38:173–178. https://doi.org/10.3109/03630269.2014.905792

    Article  CAS  PubMed  Google Scholar 

  32. Mirhosseini NZ, Shahar S, Ghayour-Mobarhan M, Banihashem A, Kamaruddin NA, Hatef MR, Esmaili HA (2013) Bone-related complications of transfusion-dependent beta thalassemia among children and adolescents. J Bone Miner Metab 31:468–476. https://doi.org/10.1007/s00774-013-0433-1

    Article  CAS  PubMed  Google Scholar 

  33. Singh K, Kumar R, Shukla A, Phadke SR, Agarwal S (2012) Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India. Hematology 17:291–296. https://doi.org/10.1179/1607845412Y.0000000017

    Article  CAS  PubMed  Google Scholar 

  34. Saffari F, Mahyar A, Jalilolgadr S (2012) Endocrine and metabolic disorders in β-thalassemia major patients. Casp J Intern Med 3:466–472

    CAS  Google Scholar 

  35. Wang Y, Zhao R, Gu Z, Dong C, Guo G, Li L (2020) Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis. Osteoporos Int 31:1401–1409. https://doi.org/10.1007/s00198-020-05360-w

    Article  CAS  PubMed  Google Scholar 

  36. Lewiecki EM, Binkley N, Bilezikian JP, Kendler DL, Leib ES, Petak SM (2006) Official positions of the International Society for Clinical Densitometry. Osteoporos Int 17:1700–1701. https://doi.org/10.1007/s00198-006-0202-2

    Article  PubMed  Google Scholar 

  37. Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS, Pessah-Pollack R, Tangpricha V, Wimalawansa SJ, Watts NB (2016) American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016. Endocr Pract 22:1–42. https://doi.org/10.4158/EP161435.GL

    Article  PubMed  Google Scholar 

  38. Steer K, Stavnichuk M, Morris M, Komarova SV (2017) Bone health in patients with hematopoietic disorders of bone marrow origin: systematic review and meta-analysis. J Bone Miner Res 32:731–742. https://doi.org/10.1002/jbmr.3026

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, European University Cyprus, Diogenes Street 6, Strovolos, 2404, Nicosia, Cyprus

    P.P. Manolopoulos, G. Lavranos, A. Angouridis & E.O. Johnson

  2. Department of Health Sciences, School of Sciences, European University Cyprus, Nicosia, Cyprus

    P.P. Manolopoulos, G. Lavranos, I. Mamais & K. Giannakou

Authors
  1. P.P. Manolopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Lavranos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Mamais
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Angouridis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Giannakou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E.O. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P.P. Manolopoulos.

Ethics declarations

Conflicts of interest

None

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Manolopoulos, P., Lavranos, G., Mamais, I. et al. Vitamin D and bone health status in beta thalassemia patients—systematic review. Osteoporos Int 32, 1031–1040 (2021). https://doi.org/10.1007/s00198-021-05821-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-021-05821-w

Keywords

Search

Navigation